BROSHY ERAN sold TBPH
November 11, 2025 · Form 4 insider transaction
BROSHY ERAN sold 14,000 shares of Theravance Biopharma, Inc. at $18.50 per share, a transaction worth $259.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
14,000
Price
$18.50
Total value
$259.0K
InsiderBROSHY ERAN
RoleDirector
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateNovember 11, 2025
Filing dateNovember 13, 2025
Shares owned after46,204
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes. The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024.